Which is better for men and women?
AUSTIN, Texas — Viagra maker Pfizer Inc. is making another big bet on a male-only treatment.
The company on Monday announced it has acquired a U.S. company called Viagra Pro, which makes the drug.
Pfizer will pay $3 billion for the company, which specializes in treating erectile dysfunction, a condition in which an erection does not respond to male-oriented pills like Viagra or Cialis.
It will take control of a company that has sold more than 80 million of the pills since it began manufacturing the pills in the 1970s.
Pfizers shares rose more than 1 percent.
Pfis is the third-largest U.N. aid group in the world, but the pharmaceutical industry has a history of making big bets on male-specific drugs.
Its recent move into male-related products is the latest in a string of investments that could help Pfizer become the dominant male-focused company in the U.K. and the U .
In addition to its $5 billion purchase of Ciali, Pfizer has been buying up smaller companies, including Pfizer HealthCare, which sells generic versions of male contraceptives.
Pfiser shares have risen more than 4 percent this year.
A Pfizer spokeswoman said in an emailed statement that the new Pfizer Pro deal is “the most significant of its kind in Pfizer’s history.”
It said the new deal will allow the company to “focus on its core business and accelerate its transition to an inclusive, global health care industry.”
The company has already taken steps to diversify its operations.
Pfi has recently increased its investment in generics and plans to expand its partnerships with other companies, such as Novartis AG.
Pfenzi also is pursuing deals with smaller companies that are less likely to get into the male-dominated market, like the generic-drug maker AbbVie Inc. The Abbvie deal, announced last year, was the first time the U., as a whole, has taken a step beyond a partnership with a company of a different gender.
Pfopio has also invested in generic-pill maker Takeda Pharmaceutical Co. for $4.2 billion, according to the company’s latest filing with the U